In Japan, new categories are created for medical devices with novel technologies or functions not covered by existing classifications. They undergo detailed evaluation for pricing & reimbursement under NHI. Existing categories cover devices similar to those already reimbursed, often resulting in pricing based on equivalence. New categories require additional clinical & cost-effectiveness evidence.
